InMed Pharmaceuticals (INM) Free Cash Flow Growth (1y) (2020 - 2026)
Powered by 
Analysis
InMed Pharmaceuticals (INM) Free Cash Flow Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.55 Bn | 143.04 Bn | 1.63 Bn | 223.75% |
| 2 | Ati | 28.35 Bn | 27.57 Bn | 309.80 Mn | -29.31% |
| 3 | Qnity Electronics | 26.32 Bn | 25.36 Bn | 666.00 Mn | -32.59% |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | 95.89% |
| 5 | DuPont de Nemours | 17.42 Bn | 15.68 Bn | 639.00 Mn | 1,250.00% |
| 6 | Avery Dennison | 12.98 Bn | 12.75 Bn | 729.40 Mn | 106.38% |
| 7 | Solstice Advanced Materials | 10.02 Bn | 9.27 Bn | 370.00 Mn | 67.57% |
| 8 | Element Solutions | 8.75 Bn | 8.56 Bn | 334.00 Mn | 30.60% |
| 9 | Eastman Chemical | 7.83 Bn | 7.14 Bn | 560.00 Mn | 49.40% |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | -2.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2.15% |
| Dec 31, 2025 | 5.03% |
| Sep 30, 2025 | 12.00% |
| Jun 30, 2025 | -72.81% |
| Mar 31, 2025 | 14.21% |
| Dec 31, 2024 | -34.48% |
| Sep 30, 2024 | 15.86% |
| Jun 30, 2024 | -49.21% |
| Mar 31, 2024 | -8.04% |
| Dec 31, 2023 | 31.42% |
| Sep 30, 2023 | 3.51% |
| Jun 30, 2023 | 83.05% |
| Mar 31, 2023 | 66.55% |
| Dec 31, 2022 | 18.26% |
| Sep 30, 2022 | 22.52% |
| Jun 30, 2022 | -102.86% |
| Mar 31, 2022 | -16.06% |
| Dec 31, 2021 | -84.25% |
| Sep 30, 2021 | -109.58% |
| Jun 30, 2021 | -43.53% |